These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18591893)

  • 21. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
    Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D; ElAsmar N; Arafah BM
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index.
    van Aken MO; Pereira AM; Frölich M; Romijn JA; Pijl H; Veldhuis JD; Roelfsema F
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E63-70. PubMed ID: 15328071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH-independent hypercortisolism.
    Morelli V; Minelli L; Eller-Vainicher C; Palmieri S; Cairoli E; Spada A; Arosio M; Chiodini I
    J Endocrinol Invest; 2018 Apr; 41(4):485-493. PubMed ID: 29151238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Retrospective hormonal analysis of incidentally discovered and operated adrenal tumors for subclinical Cushing's syndrome].
    Przybylik-Mazurek E; Buziak-Bereza M; Fedorowicz A; Kuźniarz-Rymarz S; Stochmal E; Hubalewska-Dydejczyk A
    Przegl Lek; 2010; 67(12):1270-5. PubMed ID: 21591352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of aldosterone synthase and adrenocorticotropic hormone receptor in adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidentaloma.
    Cao CX; Yang XC; Gao YX; Zhuang M; Wang KP; Sun LJ; Wang XS
    Int J Mol Med; 2012 Dec; 30(6):1396-402. PubMed ID: 23023242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidentally discovered myelolipomatous adrenal adenomas, including six cases presenting with hypercortisolism.
    Collins K; Oramas DM; Guccione J; Elsayes KM; Habra MA; Zhang M; Cheng L
    Pathol Res Pract; 2021 Aug; 224():153508. PubMed ID: 34119816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma.
    La Cava G; Imperiale A; Olianti C; Gheri GR; Ladu C; Mannelli M; Pupi A
    J Nucl Med; 2003 Jul; 44(7):1057-64. PubMed ID: 12843220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels.
    Yener S; Comlekci A; Akinci B; Secil M; Demir T; Ertilav S; Yesil S
    J Endocrinol Invest; 2009 Apr; 32(4):338-43. PubMed ID: 19636203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scanning of the adrenals in Cushing's syndrome.
    Gogas JG; Skalkeas GD; Sechas MN; Skandalakis PN
    Am Surg; 1987 Aug; 53(8):472-5. PubMed ID: 3605868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications.
    Ivović M; Marina LV; Vujović S; Tančić-Gajić M; Stojanović M; Radonjić NV; Gajić M; Soldatović I; Micić D
    Metabolism; 2013 Jun; 62(6):786-92. PubMed ID: 23332445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma.
    Francucci CM; Pantanetti P; Garrapa GG; Massi F; Arnaldi G; Mantero F
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):587-93. PubMed ID: 12390331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas.
    Delivanis DA; Iñiguez-Ariza NM; Zeb MH; Moynagh MR; Takahashi N; McKenzie TJ; Thomas MA; Gogos C; Young WF; Bancos I; Kyriazopoulou V
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):209-216. PubMed ID: 29115003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
    Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of overt Cushing's syndrome in patients with adrenal incidentaloma.
    Barzon L; Fallo F; Sonino N; Boscaro M
    Eur J Endocrinol; 2002 Jan; 146(1):61-6. PubMed ID: 11751069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenal incidentaloma, a five year experience.
    Terzolo M; Osella G; Alì A; Reimondo G; Borretta G; Magro GP; Luceri S; Paccotti P; Angeli A
    Minerva Endocrinol; 1995 Mar; 20(1):69-78. PubMed ID: 7651285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
    Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome.
    Bui F; Macri' C; Varotto L; Boscaro M; Mantero F
    Cardiology; 1985; 72 Suppl 1():76-83. PubMed ID: 2996768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.